Form 8-K - Current report:
SEC Accession No. 0001493152-24-033444
Filing Date
2024-08-21
Accepted
2024-08-21 16:15:34
Documents
16
Period of Report
2024-08-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 72286
2 ex3-1.htm EX-3.1 16183
3 ex3-2.htm EX-3.2 68258
4 ex10-1.htm EX-10.1 13487
  Complete submission text file 0001493152-24-033444.txt   369460

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE nrxs-20240815.xsd EX-101.SCH 3015
6 XBRL LABEL FILE nrxs-20240815_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE nrxs-20240815_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3790
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 241228910
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)